JRSS — JRSIS HEALTH CARE Income Statement
0.000.00%
- $1.95m
- $3.25m
- $3.46m
Annual income statement for JRSIS HEALTH CARE, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | R2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 31.5 | 35.7 | 0 | 0.089 | 3.46 |
| Cost of Revenue | |||||
| Gross Profit | 23.6 | 28.9 | — | — | 0.483 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 26.8 | 30.1 | 0.104 | 0.415 | 3.65 |
| Operating Profit | 4.67 | 5.59 | -0.104 | -0.326 | -0.189 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 1.93 | 5.2 | -0.104 | -0.328 | -0.086 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 1.27 | 3.83 | -0.104 | -0.328 | -0.095 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | 0.888 | 2.68 | 3.19 | -33.7 | -0.081 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 0.888 | 2.68 | 3.19 | -33.7 | -0.081 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.529 | 1.47 | -0.056 | -0.073 | -0.001 |